NCT04627883

Brief Summary

The purpose of this study is to investigate the clinical application value of inverse ratio ventilation in obese patients during induction of general anesthesia by studying the effect of inverse ratio ventilation on the safe apnea time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 17, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 11, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 13, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

February 17, 2025

Status Verified

October 1, 2020

Enrollment Period

1.4 years

First QC Date

October 11, 2020

Last Update Submit

February 13, 2025

Conditions

Keywords

inverse ratio ventilationsafe apnea time

Outcome Measures

Primary Outcomes (1)

  • Safe Apnea Time

    The safe apnea time was defined as that period of time during which the arterial saturation as measured by pulse oximetry remained at or above 93% .

    The arterial saturation as measured by pulse oximetry remained at or above 93% after endotracheal intubation immediately.

Secondary Outcomes (3)

  • EtO2

    After 3 minutes of preoxygenation After 5 minutes of noninvasive positive pressure ventilation

  • EtO2

    After 3 minutes of noninvasive positive pressure ventilation

  • EtO2

    After 5 minutes of noninvasive positive pressure ventilation

Study Arms (2)

Group 1:2

OTHER

Patients in the control group had noninvasive positive pressure ventilation with inspiratory-to-expiratory (I : E) ratio of 1:2.

Other: Inspiratory-to-expiratory (I : E) ratio of 1:2

Group 2:1

OTHER

Patients in the IRV group had noninvasive positive pressure ventilation with inspiratory-to-expiratory (I : E) ratio of 2:1.

Other: Inspiratory-to-expiratory (I : E) ratio of 2:1

Interventions

After preoxygenation and induction of anesthesia, noninvasive positive pressure ventilation with inspiratory-to-expiratory (I : E) ratio of 1:2 for 5 min before endotracheal intubation.

Group 1:2

After preoxygenation and induction of anesthesian, noninvasive positive pressure ventilation with inspiratory-to-expiratory (I : E) ratio of 2:1 for 5 min before endotracheal intubation.

Group 2:1

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obese patients, aged 18-65 years, of either gender, ASA grade II-III, body mass index (BMI) \> 30 kg / m2, scheduled for general anesthesia under tracheal intubation, signed informed consent.

You may not qualify if:

  • Patients who need rapid sequence induction (RSI); patients with expected difficult airway; severe chronic respiratory diseases, such as tuberculosis, bronchitis, bronchial asthma and COPD; patients with severe cardiovascular diseases, such as severe ischemic heart disease and pulmonary hypertension; patients with severe cerebrovascular diseases, such as cerebral hemorrhage and cerebral infarction; patients with abnormal basal metabolic rate, such as pregnancy, thyrotoxicosis, pheochromocytoma; and severe stomach reflux disease; patients with abnormal hemoglobin and hematocrit.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

General Hospital of Ningxia Medical University

General Hospital of Ningxia Medical University, Ningxia, 750004, China

Location

General Hospital of Ningxia Medical University

Yinchuan, Ningxia, 750004, China

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2020

First Posted

November 13, 2020

Study Start

August 17, 2020

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

February 17, 2025

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations